AdipoPharma is a French biotech company committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis
AdipoPharma is a French biotech company committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. The company is developing PATAS, a first-in-class insulin sensitizer targeting insulin resistance and type 2 diabetes.